20:04 EST Cathie Wood’s ARK Investment buys 96.2K shares of Intellia Therapeutics (NTLA) today
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NTLA:
- Biotech Alert: Searches spiking for these stocks today
- Intellia announces FDA granted RMAT designation to nexiguran ziclumeran
- Cathie Wood’s ARK Investment buys 223.5K shares of Intellia Therapeutics today
- Intellia Therapeutics Announces Promising CRISPR Therapy Results
- Intellia Therapeutics price target lowered to $70 from $80 at Wells Fargo